CytomX Therapeutics (CTMX) Intangibles (2014 - 2026)
CytomX Therapeutics (CTMX) posted Intangibles of $401000.0 for Q1 2026, down 8.45% on a QoQ basis from $438000.0 in Q4 2025, and down 26.69% year-over-year from $547000.0 in Q1 2025.
CytomX Therapeutics (CTMX) Intangibles (2014 - 2026) Analysis & Trends
CytomX Therapeutics' Intangibles history runs 13 years deep, the most recent figure standing at $401000.0 for Q1 2026.
- Quarterly Intangibles fell 26.69% year-over-year to $401000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $401000.0 (down 26.69% YoY) and the FY2025 annual result came in at $438000.0, down 24.87% from the prior year.
- Intangibles was $401000.0 for Q1 2026 at CytomX Therapeutics, down from $438000.0 in the prior quarter.
- Across five years, Intangibles topped out at $984000.0 in Q1 2022 and bottomed at $401000.0 in Q1 2026.
- A 5-year average of $692705.9 and a median of $693000.0 in 2024 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2022 — Intangibles decreased 12.92% — and 2026, when it declined 26.69%.
- CytomX Therapeutics' Intangibles stood at $875000.0 in 2022, then fell by 16.69% to $729000.0 in 2023, then decreased by 20.03% to $583000.0 in 2024, then slipped by 24.87% to $438000.0 in 2025, then declined by 8.45% to $401000.0 in 2026.
- Business Quant data shows CTMX's Intangibles at $401000.0 in Q1 2026, $438000.0 in Q4 2025, and $474000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 11,640.44 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 30.30 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 61.68 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 55.80 Mn |
| 10 | CytomX Therapeutics | 574.36 Mn | 227.66 Mn | - | 401,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 401,000.00 |
| Dec 31, 2025 | 438,000.00 |
| Sep 30, 2025 | 474,000.00 |
| Jun 30, 2025 | 510,000.00 |
| Mar 31, 2025 | 547,000.00 |
| Dec 31, 2024 | 583,000.00 |
| Sep 30, 2024 | 620,000.00 |
| Jun 30, 2024 | 656,000.00 |
| Mar 31, 2024 | 693,000.00 |
| Dec 31, 2023 | 729,000.00 |
| Sep 30, 2023 | 766,000.00 |
| Jun 30, 2023 | 802,000.00 |
| Mar 31, 2023 | 839,000.00 |
| Dec 31, 2022 | 875,000.00 |
| Sep 30, 2022 | 911,000.00 |
| Jun 30, 2022 | 948,000.00 |
| Mar 31, 2022 | 984,000.00 |
| Dec 31, 2021 | 1.02 Mn |
| Sep 30, 2021 | 1.06 Mn |
| Jun 30, 2021 | 1.09 Mn |